Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense

Press/Media: Research

Period	Jul 28 2025

Media coverage

Title	Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense
Media name/outlet	Dove Medical Press
Country/Territory	United Kingdom
Date	7/28/25
URL	https://www.dovepress.com/astragaloside-iv-attenuates-chronic-prostatitis-by-activating-keap1nrf-peer-reviewed-fulltext-article-JIR
Persons	Bin Zhang